We are live on
!
Find out more
Aristotle Capital Management Portfolio holdings
AUM
$47.8B
1-Year Est. Return
13.38%
This Fund
S&P 500
This Quarter
Est. Return
+12.81%
1 Year Est. Return
+13.38%
3 Year Est. Return
+48.4%
5 Year Est. Return
+59.36%
10 Year Est. Return
+297.67%
AUM
$16.8B
AUM Growth
+$2.02B
(+14%)
Cap. Flow
+$258M
Cap. Flow
% of AUM
1.53%
Top 10 Holdings %
Top 10 Hldgs %
32.77%
Holding
182
New
10
Increased
119
Reduced
29
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tyson Foods
TSN
|
+$119M |
| 2 |
Allegion
ALLE
|
+$80M |
| 3 |
Novartis
NVS
|
+$38.7M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$26.5M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$190M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$167M |
| 3 |
Kroger
KR
|
+$107M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$45.7M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$12.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.97% |
| 2 | Technology | 16.63% |
| 3 | Healthcare | 14.79% |
| 4 | Industrials | 10.08% |
| 5 | Energy | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Zimmer Biomet
ZBH
$18.2B
| $577K | ﹤0.01% |
4,653
+18
| +0.4% | +$2.05K |
|
102
iShares Global Healthcare ETF
IXJ
$4.07B
| $544K | ﹤0.01% |
+8,900
| New | +$530K |
|
103
Chevron
CVX
$392B
| $538K | ﹤0.01% |
4,370
+8
| +0.2% | +$946 |
|
104
Visa
V
$684B
| $422K | ﹤0.01% |
2,700
| – | – |
|
105
Archer Daniels Midland
ADM
$38.2B
| $381K | ﹤0.01% |
8,839
-4,336
| -33% | -$185K |
|
106
Apple
AAPL
$4.54T
| $380K | ﹤0.01% |
8,000
-3,200
| -29% | -$136K |
|
107
iShares MSCI Emerging Markets ETF
EEM
$28.8B
| $342K | ﹤0.01% |
7,970
+2,300
| +41% | +$96.8K |
|
108
Wells Fargo
WFC
$261B
| $319K | ﹤0.01% |
6,600
| – | – |
|
109
Procter & Gamble
PG
$336B
| $301K | ﹤0.01% |
2,896
| – | – |
|
110
Becton Dickinson
BDX
$45.6B
| $300K | ﹤0.01% |
1,230
| – | – |
|
111
Starbucks
SBUX
$120B
| $297K | ﹤0.01% |
4,000
-500
| -11% | -$34.4K |
|
112
AT&T
T
$159B
| $283K | ﹤0.01% |
11,950
+170
| +1% | +$3.91K |
|
113
Stryker
SYK
$125B
| $279K | ﹤0.01% |
1,413
+13
| +0.9% | +$2.34K |
|
114
Costco
COST
$422B
| $266K | ﹤0.01% |
1,100
| – | – |
|
115
Intel
INTC
$455B
| $256K | ﹤0.01% |
4,766
-800
| -14% | -$40.6K |
|
116
RTX Corp
RTX
$290B
| $245K | ﹤0.01% |
3,025
+6
| +0.2% | +$456 |
|
117
Masco
MAS
$14.1B
| $240K | ﹤0.01% |
+6,100
| New | +$218K |
|
118
AES
AES
$10.5B
| – | – |
-10,894
| Closed | -$158K |
|
119
Vanguard Morningstar Value ETF
VTV
$188B
| – | – |
-17,261
| Closed | -$1.69M |
|
Similar funds
TI
RIM
Aristotle Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Aristotle Capital Management held 182 positions worth $16.8B, up 14% from $14.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Aristotle Capital Management's Q1 2019 filing shows 10 new, 119 increased, 29 reduced and 10 closed positions. Its largest new stake was Tyson Foods: 1,926,207 shares worth $134M. The largest sale was AbbVie, an estimated $190M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Technology and Healthcare.
- Aristotle Capital Management's largest Q1 2019 buy was Tyson Foods: 1,926,207 shares worth $134M.
- Aristotle Capital Management added most to Novartis in Q1 2019, an estimated $38.7M increase.
- Aristotle Capital Management's biggest Q1 2019 reduction was AbbVie, cutting an estimated $190M.
- Aristotle Capital Management fully exited Vanguard Morningstar Value ETF in Q1 2019, selling an estimated $1.69M.
- Aristotle Capital Management's ten largest holdings make up 33% of its $16.8B portfolio in Q1 2019.
- Aristotle Capital Management opened 10 new positions and closed 10 in Q1 2019.
- Aristotle Capital Management's portfolio value rose 14% quarter-over-quarter to $16.8B.
Based on Aristotle Capital Management's 13F filing for Q1 2019, filed 15 May 2019.